Literature DB >> 20442399

Autologous extracellular cytochrome c is an endogenous ligand for leucine-rich alpha2-glycoprotein and beta-type phospholipase A2 inhibitor.

Ryoichi Shirai1, Rikiya Gotou, Fumiyasu Hirano, Kiyoshi Ikeda, Seiji Inoue.   

Abstract

Beta-type phospholipase A(2) inhibitory protein (PLIbeta) from the serum of the venomous snake Gloydius brevicaudus neutralizes basic phospholipase A(2) (PLA(2)) from its own venom, and it has 33% sequence homology with human leucine-rich alpha(2)-glycoprotein (LRG), which has been recently reported to bind cytochrome c (Cyt c) (Cummings, C., Walder, J., Treeful, A., and Jemmerson, R. (2006) Apoptosis 11, 1121-1129). In the present study, PLIbeta was found to bind Cyt c. The interactions of LRG and PLIbeta with Cyt c were compared by surface plasmon resonance analysis. Human LRG bound horse and snake Cyt c with dissociation constants of 1.58 x 10(-13) M and 1.65 x 10(-10) M, respectively, but did not bind yeast Cyt c, while G. brevicaudus PLIbeta bound horse, snake, and yeast Cyt c with dissociation constants of 1.05 x 10(-10) M, 2.37 x 10(-12) M, and 1.67 x 10(-6) M, respectively. On the other hand, LRG did not show any PLA(2) inhibitory activity and did not bind G. brevicaudus basic PLA(2), whereas PLIbeta bound the basic PLA(2) with a dissociation constant of 1.21 x 10(-9) M, which is smaller than those with the Cyt c described above. The PLA(2) inhibitory activity of PLIbeta was also found to be suppressed by the binding of Cyt c to PLIbeta. These results suggest that autologous Cyt c is an endogeneous ligand for LRG and PLIbeta and that these serum proteins neutralize the autologous Cyt c released from the dead cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442399      PMCID: PMC2898406          DOI: 10.1074/jbc.M110.122788

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY.

Authors:  L ORNSTEIN
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Spectrum of horse-heart cytochrome c.

Authors:  E MARGOLIASH; N FROHWIRT
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

3.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

4.  A novel phospholipase A2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffii siniticus. Sequence homologies with human leucine-rich alpha2-glycoprotein.

Authors:  K Okumura; N Ohkura; S Inoue; K Ikeda; K Hayashi
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

5.  Purification and characterization of three distinct types of phospholipase A2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus.

Authors:  N Ohkura; H Okuhara; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.

Authors:  H Zou; Y Li; X Liu; X Wang
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 7.  Receptors for a growing family of secreted phospholipases A2.

Authors:  G Lambeau; M Lazdunski
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

8.  Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Specificity of two types of phospholipase A2 inhibitors from the plasma of venomous snakes.

Authors:  S Inoue; A Shimada; N Ohkura; K Ikeda; Y Samejima; T Omori-Satoh; K Hayashi
Journal:  Biochem Mol Biol Int       Date:  1997-03

10.  A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin.

Authors:  F Radvanyi; L Jordan; F Russo-Marie; C Bon
Journal:  Anal Biochem       Date:  1989-02-15       Impact factor: 3.365

View more
  5 in total

1.  Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.

Authors:  Lawrence J Druhan; Amanda Lance; Shimena Li; Andrea E Price; Jacob T Emerson; Sarah A Baxter; Jonathan M Gerber; Belinda R Avalos
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

2.  Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter.

Authors:  Qian Zhang; Rui Huang; Qingchao Tang; Yang Yu; Quanlong Huang; Yinggang Chen; Guiyu Wang; Xishan Wang
Journal:  Onco Targets Ther       Date:  2018-05-11       Impact factor: 4.147

3.  Identification, description and structural analysis of beta phospholipase A2 inhibitors (sbβPLIs) from Latin American pit vipers indicate a binding site region for basic snake venom phospholipases A2.

Authors:  Consuelo Latorre Fortes-Dias; Carlos Alexandre H Fernandes; Paula Ladeira Ortolani; Patrícia Cota Campos; L A Melo; Liza Figueiredo Felicori; Marcos Roberto M Fontes
Journal:  Toxicon X       Date:  2019-02-26

4.  Intracellular leucine-rich alpha-2-glycoprotein-1 competes with Apaf-1 for binding cytochrome c in protecting MCF-7 breast cancer cells from apoptosis.

Authors:  Ronald Jemmerson; Katherine Staskus; LeeAnn Higgins; Kathleen Conklin; Ameeta Kelekar
Journal:  Apoptosis       Date:  2021-01-01       Impact factor: 4.677

5.  Biomarker discovery in serum from patients with carotid atherosclerosis.

Authors:  Thomas J Degraba; Gerard T Hoehn; Paul A Nyquist; Honghui Wang; Ray Kenney; Denise A Gonzales; Steven J Kern; Sai-Xia Ying; Peter J Munson; Anthony F Suffredini
Journal:  Cerebrovasc Dis Extra       Date:  2011-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.